{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:24Z","timestamp":1772166324660,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR AAP19 METAVAC-T17"],"award-info":[{"award-number":["ANR AAP19 METAVAC-T17"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      To produce viral vaccines, avian cell lines are interesting alternatives to replace the egg-derived processes for viruses that do not grow well on mammalian cells. The avian suspension cell line DuckCelt\n                      <jats:sup>\u00ae<\/jats:sup>\n                      -T17 was previously studied and investigated to produce a live attenuated metapneumovirus (hMPV)\/respiratory syncytial virus (RSV) and influenza virus vaccines. However, a better understanding of its culture process is necessary for an efficient production of viral particles in bioreactors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The growth and metabolic requirements of the avian cell line DuckCelt\n                      <jats:sup>\u00ae<\/jats:sup>\n                      -T17 were investigated to improve its cultivation parameters. Several nutrient supplementation strategies were studied in shake flasks highlighting the interest of\n                      <jats:italic>(i)<\/jats:italic>\n                      replacing L-glutamine by glutamax as main nutrient or\n                      <jats:italic>(ii)<\/jats:italic>\n                      adding these two nutrients in the serum-free growth medium in a fed-batch strategy. The scale-up in a 3\u00a0L bioreactor was successful for these types of strategies confirming their efficiencies in improving the cells\u2019 growth and viability. Moreover, a perfusion feasibility test allowed to achieve up to ~\u20093 times the maximum number of viable cells obtained with the batch or fed-batch strategies. Finally, a strong oxygen supply \u2013 50% dO\n                      <jats:sub>2<\/jats:sub>\n                      \u2013 had a deleterious effect on DuckCelt\n                      <jats:sup>\u00ae<\/jats:sup>\n                      -T17 viability, certainly because of the greater hydrodynamic stress imposed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The culture process using glutamax supplementation with a batch or a fed-batch strategy was successfully scaled-up to 3\u00a0L bioreactor. In addition, perfusion appeared as a very promising culture process for subsequent continuous virus harvesting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13036-023-00349-5","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T10:02:09Z","timestamp":1682330529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Experimental studies from shake flasks to 3\u00a0L stirred tank bioreactor of nutrients and oxygen supply conditions to improve the growth of the avian cell line DuckCelt\u00ae-T17"],"prefix":"10.1186","volume":"17","author":[{"given":"Valentine","family":"Tingaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Bordes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyad","family":"Al Mouazen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cogn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Alexandrine","family":"Bolzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"349_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.sjbs.2019.10.002","volume":"27","author":"R Andleeb","year":"2020","unstructured":"Andleeb R, Ashraf A, Muzammil S, Naz S, et al. Analysis of bioactive composites and antiviral activity of Iresine herbstii extracts against Newcastle disease virus in ovo. Saudi J Biol Sci. 2020;27:335\u201340.","journal-title":"Saudi J Biol Sci"},{"key":"349_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s12033-018-0128-x","volume":"60","author":"RM Woodfint","year":"2018","unstructured":"Woodfint RM, Hamlin E, Lee K. Avian Bioreactor Systems: a review. Mol Biotechnol. 2018;60:975\u201383.","journal-title":"Mol Biotechnol"},{"key":"349_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/clinids\/2.3.493","volume":"2","author":"JF Enders","year":"1980","unstructured":"Enders JF, Robbins FC, Weller TH. The cultivation of the Poliomyelitis Viruses in tissue culture. Clin Infect Dis. 1980;2:493\u2013504.","journal-title":"Clin Infect Dis"},{"key":"349_CR4","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/bit.22753","volume":"106","author":"M George","year":"2010","unstructured":"George M, Farooq M, Dang T, Cortes B, et al. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process. Biotechnol Bioeng. 2010;106:906\u201317.","journal-title":"Biotechnol Bioeng"},{"key":"349_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00253-004-1874-1","volume":"67","author":"N Bardiya","year":"2005","unstructured":"Bardiya N, Bae JH. Influenza vaccines: recent advances in production technologies. Appl Microbiol Biotechnol. 2005;67:299\u2013305.","journal-title":"Appl Microbiol Biotechnol"},{"key":"349_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.vaccine.2012.10.070","volume":"31","author":"BP Sanders","year":"2013","unstructured":"Sanders BP, Edo-Matas D, Custers JHHV, Koldijk MH, et al. PER.C6\u00ae cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine. Vaccine. 2013;31:850\u20136.","journal-title":"Vaccine"},{"key":"349_CR7","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1016\/S0264-410X(00)00508-9","volume":"19","author":"MG Pau","year":"2001","unstructured":"Pau MG, Ophorst C, Koldijk MH, Schouten G, et al. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine. 2001;19:2716\u201321.","journal-title":"Vaccine"},{"key":"349_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.vaccine.2008.11.066","volume":"27","author":"I Jordan","year":"2009","unstructured":"Jordan I, Vos A, Beilfu\u00df S, Neubert A, et al. An avian cell line designed for production of highly attenuated viruses. Vaccine. 2009;27:748\u201356.","journal-title":"Vaccine"},{"key":"349_CR9","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1586\/erv.09.128","volume":"8","author":"Y Genzel","year":"2009","unstructured":"Genzel Y, Reichl U. Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines. 2009;8:1681\u201392.","journal-title":"Expert Rev Vaccines"},{"key":"349_CR10","doi-asserted-by":"crossref","unstructured":"Olivier S, Jacoby M, Brillon C, Bouletreau S et al. EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity. MAbs 2010, 2, 405\u2013415.","DOI":"10.4161\/mabs.12350"},{"key":"349_CR11","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1016\/j.vaccine.2016.10.043","volume":"34","author":"A L\u00e9on","year":"2016","unstructured":"L\u00e9on A, David A-L, Madeline B, Guianvarc\u2019h L, et al. The EB66\u00ae cell line as a valuable cell substrate for MVA-based vaccines production. Vaccine. 2016;34:5878\u201385.","journal-title":"Vaccine"},{"key":"349_CR12","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1007\/s00253-018-9275-z","volume":"102","author":"A Nikolay","year":"2018","unstructured":"Nikolay A, L\u00e9on A, Schwamborn K, Genzel Y, et al. Process intensification of EB66\u00ae cell cultivations leads to high-yield yellow fever and Zika virus production. Appl Microbiol Biotechnol. 2018;102:8725\u201337.","journal-title":"Appl Microbiol Biotechnol"},{"key":"349_CR13","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1016\/j.vaccine.2009.05.083","volume":"27","author":"V Lohr","year":"2009","unstructured":"Lohr V, Rath A, Genzel Y, Jordan I, et al. New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine. 2009;27:4975\u201382.","journal-title":"Vaccine"},{"key":"349_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1472-6750-12-79","volume":"12","author":"V Lohr","year":"2012","unstructured":"Lohr V, Genzel Y, Jordan I, Katinger D, et al. Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells. BMC Biotechnol. 2012;12:79.","journal-title":"BMC Biotechnol"},{"key":"349_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1472-6750-14-72","volume":"14","author":"V Lohr","year":"2014","unstructured":"Lohr V, H\u00e4dicke O, Genzel Y, Jordan I, et al. The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis. BMC Biotechnol. 2014;14:72.","journal-title":"BMC Biotechnol"},{"key":"349_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00253-017-8660-3","volume":"102","author":"MA Wasik","year":"2018","unstructured":"Wasik MA, Eichwald L, Genzel Y, Reichl U. Cell culture-based production of defective interfering particles for influenza antiviral therapy. Appl Microbiol Biotechnol. 2018;102:1167\u201377.","journal-title":"Appl Microbiol Biotechnol"},{"key":"349_CR17","doi-asserted-by":"publisher","first-page":"012029","DOI":"10.1088\/1757-899X\/778\/1\/012029","volume":"778","author":"FN Aliya Mohamad Ros","year":"2020","unstructured":"Aliya Mohamad Ros FN, Abd Rahman N, Ali M, Anuar J. Comparative study between avian cell and mammalian cell in production of Influenza Vaccine Shariah Compliance. IOP Conf Ser Mater Sci Eng. 2020;778:012029.","journal-title":"IOP Conf Ser Mater Sci Eng"},{"key":"349_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fbioe.2020.00672","volume":"8","author":"J Coronel","year":"2020","unstructured":"Coronel J, Gr\u00e4nicher G, Sandig V, Noll T, et al. Application of an inclined settler for Cell Culture-Based influenza a Virus production in Perfusion Mode. Front Bioeng Biotechnol. 2020;8:672.","journal-title":"Front Bioeng Biotechnol"},{"key":"349_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/biot.201400388","volume":"10","author":"Y Genzel","year":"2015","unstructured":"Genzel Y. Designing cell lines for viral vaccine production: where do we stand? Biotechnol J. 2015;10:728\u201340.","journal-title":"Biotechnol J"},{"key":"349_CR20","doi-asserted-by":"crossref","unstructured":"Petiot E, Proust A, Traversier A, Durous L et al. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt\u00ae-T17. Vaccine 2018, 36, 3101\u20133111.","DOI":"10.1016\/j.vaccine.2017.03.102"},{"key":"349_CR21","doi-asserted-by":"crossref","unstructured":"L\u00ea VB, Dubois J, Couture C, Cavanagh M-H et al. Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice.PLOS Pathog.2019, 15, e1007689.","DOI":"10.1371\/journal.ppat.1007689"},{"key":"349_CR22","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/vaccines9101190","volume":"9","author":"C Chupin","year":"2021","unstructured":"Chupin C, Pizzorno A, Traversier A, Brun P, et al. Avian cell line DuckCelt\u00ae-T17 is an efficient production system for live-attenuated human metapneumovirus vaccine candidate Metavac\u00ae. Vaccines. 2021;9:1190.","journal-title":"Vaccines"},{"key":"349_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bej.2014.06.001","volume":"90","author":"K Trabelsi","year":"2014","unstructured":"Trabelsi K, Majoul S, Rourou S, Kallel H. Process intensification for an enhanced replication of a newly adapted RM-65 sheep pox virus strain in Vero cells grown in stirred bioreactor. Biochem Eng J. 2014;90:131\u20139.","journal-title":"Biochem Eng J"},{"key":"349_CR24","doi-asserted-by":"crossref","unstructured":"Marc A, Olmos \u00c9. Proc\u00e9d\u00e9s de culture en masse de cellules animales. 2010, 22.","DOI":"10.51257\/a-v1-bio6800"},{"key":"349_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0141-0229(00)00151-4","volume":"27","author":"HJ Cruz","year":"2000","unstructured":"Cruz HJ, Freitas CM, Alves PM, Moreira JL, et al. Effects of ammonia and lactate on growth, metabolism, and productivity of BHK cells. Enzyme Microb Technol. 2000;27:43\u201352.","journal-title":"Enzyme Microb Technol"},{"key":"349_CR26","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.1007\/s00253-019-09989-4","volume":"103","author":"I Mart\u00ednez-Monge","year":"2019","unstructured":"Mart\u00ednez-Monge I, Roman R, Comas P, Fontova A, et al. New developments in online OUR monitoring and its application to animal cell cultures. Appl Microbiol Biotechnol. 2019;103:6903\u201317.","journal-title":"Appl Microbiol Biotechnol"},{"key":"349_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-319-10320-4_5","volume-title":"Animal Cell Culture","author":"AW Nienow","year":"2015","unstructured":"Nienow AW. Mass transfer and mixing across the Scales in Animal Cell Culture. In: Al-Rubeai M, editor. Animal Cell Culture. Cham: Springer International Publishing; 2015. pp. 137\u201367."},{"key":"349_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bej.2013.04.011","volume":"76","author":"AW Nienow","year":"2013","unstructured":"Nienow AW, Rielly CD, Brosnan K, Bargh N, et al. The physical characterisation of a microscale parallel bioreactor platform with an industrial CHO cell line expressing an IgG4. Biochem Eng J. 2013;76:25\u201336.","journal-title":"Biochem Eng J"},{"key":"349_CR29","doi-asserted-by":"publisher","first-page":"107638","DOI":"10.1016\/j.bej.2020.107638","volume":"160","author":"Z Huang","year":"2020","unstructured":"Huang Z, Xu J, Yongky A, Morris CS, et al. CHO cell productivity improvement by genome-scale modeling and pathway analysis: application to feed supplements. Biochem Eng J. 2020;160:107638.","journal-title":"Biochem Eng J"},{"key":"349_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00253-012-4238-2","volume":"97","author":"Y Genzel","year":"2013","unstructured":"Genzel Y, Behrendt I, R\u00f6dig J, Rapp E, et al. CAP, a new human suspension cell line for influenza virus production. Appl Microbiol Biotechnol. 2013;97:111\u201322.","journal-title":"Appl Microbiol Biotechnol"},{"key":"349_CR31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jbiotec.2005.05.016","volume":"118","author":"Y-S Tsao","year":"2005","unstructured":"Tsao Y-S, Cardoso AG, Condon RGG, Voloch M, et al. Monitoring chinese hamster ovary cell culture by the analysis of glucose and lactate metabolism. J Biotechnol. 2005;118:316\u201327.","journal-title":"J Biotechnol"},{"key":"349_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/07388550903062314","volume":"29","author":"S Suresh","year":"2009","unstructured":"Suresh S, Srivastava VC, Mishra IM. Critical analysis of engineering aspects of shaken flask bioreactors. Crit Rev Biotechnol. 2009;29:255\u201378.","journal-title":"Crit Rev Biotechnol"},{"key":"349_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/ijms19020385","volume":"19","author":"N Freund","year":"2018","unstructured":"Freund N, Croughan M. A simple method to reduce both lactic acid and ammonium production in Industrial Animal Cell Culture. Int J Mol Sci. 2018;19:385.","journal-title":"Int J Mol Sci"},{"key":"349_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ymben.2011.12.006","volume":"14","author":"BC Mulukutla","year":"2012","unstructured":"Mulukutla BC, Gramer M, Hu W-S. On metabolic shift to lactate consumption in fed-batch culture of mammalian cells. Metab Eng. 2012;14:138\u201349.","journal-title":"Metab Eng"},{"key":"349_CR35","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.procbio.2006.06.018","volume":"41","author":"H Huang","year":"2006","unstructured":"Huang H, Yi X, Zhang Y. Improvement of Vero cell growth in glutamate-based culture by supplementing ammoniagenic compounds. Process Biochem. 2006;41:2386\u201392.","journal-title":"Process Biochem"},{"key":"349_CR36","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1007\/s00253-021-11561-y","volume":"105","author":"MD Hein","year":"2021","unstructured":"Hein MD, Chawla A, Cattaneo M, Kupke SY, et al. Cell culture\u2013based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Appl Microbiol Biotechnol. 2021;105:7251\u201364.","journal-title":"Appl Microbiol Biotechnol"},{"key":"349_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fbioe.2019.00078","volume":"7","author":"TA Grein","year":"2019","unstructured":"Grein TA, Loewe D, Dieken H, Weidner T, et al. Aeration and shear stress are critical process parameters for the production of Oncolytic Measles Virus. Front Bioeng Biotechnol. 2019;7:78.","journal-title":"Front Bioeng Biotechnol"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-023-00349-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-023-00349-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-023-00349-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T10:03:18Z","timestamp":1682330598000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbioleng.biomedcentral.com\/articles\/10.1186\/s13036-023-00349-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1186\/s13036-023-00349-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2459112\/v1","asserted-by":"object"}]},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"assertion":[{"value":"9 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}